Literature DB >> 4598840

Resistance of group A beta-hemolytic streptococci to lincomycin and erythromycin.

J M Dixon, A E Lipinski.   

Abstract

Ten (0.05%) of 18,628 strains of Streptococcus pyogenes isolated from clinical specimens in the 3 years 1968 to 1970 were resistant to lincomycin and erythromycin. All 10 strains were highly resistant to lincomycin, having minimal inhibitory concentration (MIC) values of 200 mug/ml. There were two degrees of resistance to erythromycin: four strains were highly resistant, having MIC values of 200 mug or more/ml; and six strains showed slight resistance, MIC values being 0.78 to 1.56 mug/ml. There was no known epidemiological relationship between any of the patients infected with the resistant strains, which belonged to a variety of T serotypes. A zonal pattern of resistance to lincomycin occurred in four strains, all of which were only slightly resistant to erythromycin. After incubation for 24 hr in a twofold dilution series of lincomycin in broth, the strains grew in 0.05 mug or less/ml and in 50 and 100 mug/ml, but not in intermediate concentrations. Tests in agar indicated that the bacterial population of one strain, but not of the other three, was homogeneous in respect to its ability to grow readily in low and high, but not in intermediate, concentrations. The zone phenomenon is of significance in the clinical laboratory, since unawareness of it might result in a highly resistant strain being regarded as susceptible to lincomycin in tube or plate MIC tests that do not include sufficiently high concentrations of lincomycin.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4598840      PMCID: PMC444217          DOI: 10.1128/AAC.1.4.333

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  14 in total

1.  Tetracycline resistance of group A beta hemolytic streptococci.

Authors:  H A KUHARIC; C E ROBERTS; W M KIR BY
Journal:  JAMA       Date:  1960-12-03       Impact factor: 56.272

2.  Laboratory diagnosis of streptococcal infections.

Authors:  R E WILLIAMS
Journal:  Bull World Health Organ       Date:  1958       Impact factor: 9.408

3.  The erythromycin group of antibiotics.

Authors:  L P GARROD
Journal:  Br Med J       Date:  1957-07-13

4.  Aureomycin and erythromycin therapy for str. pyogenes in burns.

Authors:  E J LOWBURY; J S CASON
Journal:  Br Med J       Date:  1954-10-16

5.  Further observations on the zone phenomenon in the bactericidal action of penicillin.

Authors:  H EAGLE
Journal:  J Bacteriol       Date:  1951-11       Impact factor: 3.490

6.  Group A Streptococcus resistant to erythromycin and lincomycin.

Authors:  J M Dixon
Journal:  Can Med Assoc J       Date:  1968-12-07       Impact factor: 8.262

7.  An unusual zone surrounding colistin discs in sensitivity tests of Serratia marcescens.

Authors:  D I Annear; J A Hudson
Journal:  Med J Aust       Date:  1970-04-25       Impact factor: 7.738

8.  Group A beta-hemolytic streptococci resistant to erythromycin and lincomycin.

Authors:  E Sanders; M T Foster; D Scott
Journal:  N Engl J Med       Date:  1968-03-07       Impact factor: 91.245

9.  Unusual resistance of Staphylococcus aureus to lincomycin and 7-chlorolincomycin.

Authors:  E J Benner; A P Adams
Journal:  Antimicrob Agents Chemother (Bethesda)       Date:  1969
View more
  22 in total

1.  Artificial elimination of drug resistance from group A beta-hemolytic streptococci.

Authors:  M Nakae; M Inoue; S Mitsuhashi
Journal:  Antimicrob Agents Chemother       Date:  1975-05       Impact factor: 5.191

2.  Susceptibility of various serogroups of streptococci to clindamycin and lincomycin.

Authors:  A W Karchmer; R C Moellering; B K Watson
Journal:  Antimicrob Agents Chemother       Date:  1975-02       Impact factor: 5.191

3.  Antimicrobial susceptibility of group B streptococci isolated from a variety of clinical sources.

Authors:  C J Baker; B J Webb; F F Barrett
Journal:  Antimicrob Agents Chemother       Date:  1976-07       Impact factor: 5.191

4.  Characterization of the antibiotic resistance plasmid ERL1 from Streptococcus pyogenes.

Authors:  H Malke; H E Jacob; K Störl
Journal:  Mol Gen Genet       Date:  1976-03-30

5.  Drug resistance in Streptococcus pyogenes isolated in Japan.

Authors:  M Nakae; T Murai; Y Kaneko; S Mitsuhashi
Journal:  Antimicrob Agents Chemother       Date:  1977-09       Impact factor: 5.191

6.  Characterization of a plasmid determining resistance to erythromycin, lincomycin, and vernamycin Balpha in a strain Streptococcus pyogenes.

Authors:  D B Clewell; A E Franke
Journal:  Antimicrob Agents Chemother       Date:  1974-05       Impact factor: 5.191

7.  Molecular cloning of an erythromycin resistance determinant in streptococci.

Authors:  D Behnke; J J Ferretti
Journal:  J Bacteriol       Date:  1980-11       Impact factor: 3.490

8.  Sequence relationships between plasmids associated with conventional MLS resistance and zonal lincomycin resistance in Streptococcus pyogenes.

Authors:  V I Golubkov; W Reichardt; A S Boitsov; I M Iontova; H Malke; A A Totolian
Journal:  Mol Gen Genet       Date:  1982

9.  R plasmids in Streptococcus agalactiae (group B).

Authors:  T Horodniceanu; D H Bouanchaud; G Bieth; Y A Chabbert
Journal:  Antimicrob Agents Chemother       Date:  1976-11       Impact factor: 5.191

10.  A family of r-determinants in Streptomyces spp. that specifies inducible resistance to macrolide, lincosamide, and streptogramin type B antibiotics.

Authors:  Y Fujisawa; B Weisblum
Journal:  J Bacteriol       Date:  1981-05       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.